At a glance
ClinicalIndex Comparison RecordN/ACompleted· 69 enrolled
Drug / intervention
Bifidobacterium Animalis Oral Product +3 moredrug
Likely dose
Amoxicillin Oral Tablet 50mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effects of the Synbiotic "Bifidobacterium Lactis B94 Plus Inulin" Addition on Standard Triple Therapy of Helicobacter Pylori Eradication in Children
In Brief
A clinical study evaluating Bifidobacterium Animalis Oral Product, Amoxicillin Oral Tablet, and 2 other interventions for Helicobacter Pylori Infection. Completed, enrolled 69 participants.
Detailed Summary
The aim of the study is to evaluate the effects of the synbiotic Bifidobacterium animalis ssp. lactis B94 plus inulin addition to the standard triple therapy on Helicobacter pylori infection eradication rates in children.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHelicobacter Pylori Infection
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2011
Primary CompletionJun 2012
Study CompletionAug 2012
First PostedMay 2017
TodayJul 2026
First PostedMay 24, 2017
Enrollment StartJun 1, 2011
Primary CompletionJun 1, 2012
Study CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 9.1 years ago
Interventions
Bifidobacterium Animalis Oral Productdrug
The synbiotic group will receive this product.
Amoxicillin Oral Tabletdrug
50mg/kg/day B.I.D.
Clarithromycin Oral Tabletdrug
15 mg/kg/day B.I.D.
Omeprazoledrug
1 mg/kg/day